TGFBR2 and neoplasm: It is interesting to note that 24/24 (=100%) of analysed advanced PDACs contained genetic alterations in at least one of all genes involved in TGF-β signaling, highlighting the crucial role of this pathway, and hence TβRII and ALK5, in this tumor type (16).